Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study.
Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study.
复制标题
DOI：
10.1002/cam4.4682
复制
发表时间：
2022-09
期刊：
影响因子：
4
通讯作者：
Carroll, Judith E.
中科院分区：
文献类型：
--
作者：
Bethea, Traci N.;Zhai, Wanting;Zhou, Xingtao;Ahles, Tim A.;Ahn, Jaeil;Cohen, Harvey J.;Dilawari, Asma A.;Graham, Deena M. A.;Jim, Heather S. L.;McDonald, Brenna C.;Nakamura, Zev M.;Patel, Sunita K.;Rentscher, Kelly E.;Root, James;Saykin, Andrew J.;Small, Brent J.;Van Dyk, Kathleen M.;Mandelblatt, Jeanne S.;Carroll, Judith E.
多项研究报告了 COVID-19 病毒大流行期间的睡眠障碍。关于这一流行病对患有乳腺癌的老年女性的睡眠和心理健康影响的数据很少。我们试图研究在大流行期间经历新的睡眠问题的患有或未患有乳腺癌的女性是否会出现抑郁和焦虑恶化的情况。积极参与纵向队列研究的年龄≥60岁、有非转移性乳腺癌病史的乳腺癌幸存者 (n = 242) 和频率匹配的非癌症对照 (n = 158) 完成了 2020 年 5 月至 9 月的 COVID-19 病毒大流行调查（答复率为 83%）。使用流行病学研究中心抑郁量表（CES-D）中的不安睡眠项目来测量事件性睡眠障碍。 CES-D 评分（减去睡眠项目）反映了抑郁症状；状态特质焦虑量表的状态焦虑分量表测量焦虑症状。多变量线性回归模型研究了从最近的大流行前调查到大流行调查，睡眠障碍的发展如何影响抑郁或焦虑症状的变化，并控制了协变量。大流行期间睡眠障碍的患病率为 22.3%，幸存者和对照组的睡眠障碍发生率分别为 10% 和 13.5%。在大流行期间，发生睡眠障碍的女性（与无睡眠障碍相比）的抑郁和焦虑症状显着增加（分别为 β = 8.16，p < 0.01 和 β = 6.14，p < 0.01），但效果与幸存者对照没有差异。 COVID-19 病毒大流行期间出现的睡眠障碍可能会对老年女性的心理健康产生负面影响，但被诊断患有非转移性疾病的乳腺癌幸存者与未患癌症的女性有着相似的经历。在这项纵向研究中，COVID-19 病毒大流行期间睡眠障碍的发展可能会增加抑郁和焦虑症状，从而对老年女性的心理健康产生负面影响。被诊断患有非转移性疾病的乳腺癌幸存者在大流行期间与年龄相仿的未患癌症的女性有相似的经历。
Several studies have reported sleep disturbances during the COVID‐19 virus pandemic. Little data exist about the impact of the pandemic on sleep and mental health among older women with breast cancer. We sought to examine whether women with and without breast cancer who experienced new sleep problems during the pandemic had worsening depression and anxiety. Breast cancer survivors aged ≥60 years with a history of nonmetastatic breast cancer (n = 242) and frequency‐matched noncancer controls (n = 158) active in a longitudinal cohort study completed a COVID‐19 virus pandemic survey from May to September 2020 (response rate 83%). Incident sleep disturbance was measured using the restless sleep item from the Center for Epidemiological Studies‐Depression Scale (CES‐D). CES‐D score (minus the sleep item) captured depressive symptoms; the State‐Anxiety subscale of the State Trait Anxiety Inventory measured anxiety symptoms. Multivariable linear regression models examined how the development of sleep disturbance affected changes in depressive or anxiety symptoms from the most recent prepandemic survey to the pandemic survey, controlling for covariates. The prevalence of sleep disturbance during the pandemic was 22.3%, with incident sleep disturbance in 10% and 13.5% of survivors and controls, respectively. Depressive and anxiety symptoms significantly increased during the pandemic among women with incident sleep disturbance (vs. no disturbance) (β = 8.16, p < 0.01 and β = 6.14, p < 0.01, respectively), but there were no survivor‐control differences in the effect. Development of sleep disturbances during the COVID‐19 virus pandemic may negatively affect older women's mental health, but breast cancer survivors diagnosed with the nonmetastatic disease had similar experiences as women without cancer. In this longitudinal study, the development of sleep disturbances during the COVID‐19 virus pandemic may have negatively affected older women's mental health by increasing symptoms of depression and anxiety. Breast cancer survivors diagnosed with non‐metastatic disease had similar experiences during the pandemic as women of similar age without cancer.
登录
查看更多内容
影响因子：
5.6
作者：
Lee, Eun;Cho, Hyong Jin;Irwin, Michael R.
通讯作者：
Irwin, Michael R.
影响因子：
18.4
作者：
Fiske A;Wetherell JL;Gatz M
通讯作者：
Gatz M
DOI：
10.1093/jnci/djy177
发表时间：
2018-12-01
期刊：
Journal of the National Cancer Institute
影响因子：
--
作者：
Carreira H;Williams R;Müller M;Harewood R;Stanway S;Bhaskaran K
通讯作者：
Bhaskaran K
DOI：
10.1093/jnci/djaa200
发表时间：
2021-08-02
期刊：
Journal of the National Cancer Institute
影响因子：
--
作者：
Jones JM;Saeed H;Katz MS;Lustberg MB;Forster VJ;Nekhlyudov L
通讯作者：
Nekhlyudov L
影响因子：
25.8
作者：
Irwin MR;Carrillo C;Sadeghi N;Bjurstrom MF;Breen EC;Olmstead R
通讯作者：
Olmstead R